Novartis’ head of discovery sciences John Tallarico said: “Light Horse’s high-calibre team has built a cutting-edge discovery platform that rapidly enables the exploration of core biological ...
the identification of novel targets and the functionalization of high-value targets,” said John Tallarico, Head of Discovery Sciences at Novartis. “This collaboration has the potential to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback